Crimean–Congo Hemorrhagic Fever Mimicking HELLP Syndrome in a Pregnant Woman and Her Infant in Kosovo: A Case Report
Abstract
:1. Introduction
2. Patients and Methods
2.1. Case Presentation 1: Pregnant Mother with Suspected HELLP Syndrome and CCHF
2.2. Case Presentation 2: Newborn Infant with CCHF, Meconium Aspiration Syndrome, and Probable Bacterial Sepsis
3. Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
CCHF | Crimean–Congo Hemorrhagic Fever |
HELLP Syndrome | Hemolysis, Elevated Liver Transaminases, Low Platelet Count |
IFT | Immunofluorescence Test |
ASAT | Aspartate Amino Transferase |
ALAT | Alanine Amino Transferase |
LDH | Lactate Dehydrogenase |
PTT | Partial Thromboplastine Time |
References
- Frank, M.G.; Weaver, G.; Raabe, V. State of the Clinical Science Working Group of the National Emerging Pathogens Training and Education Center’s Special Pathogens Research Network. Crimean Congo Hemorrhagic Fever Virus for Clinicians—Virology, Pathogenesis, and Pathology. Emerg. Infect. Dis. 2024, 30, 847–853. [Google Scholar] [CrossRef] [PubMed]
- Ahmeti, S.; Berisha, L.; Halili, B.; Ahmeti, F.; von Possel, R.; Thomé-Bolduan, C.; Michel, A.; Priesnitz, S.; Reisinger, E.C.; Günther, S.; et al. Crimean-Congo Hemorrhagic Fever, Kosova, 2013–2016. Emerg. Infect. Dis. 2019, 25, 321–324. [Google Scholar] [CrossRef] [PubMed]
- Duh, D.; Nichol, S.T.; Khristova, M.L.; Saksida, A.; Hafner-Bratkovič, I.; Petrovec, M.; Dedushaj, I.; Ahmeti, S.; Avšič-Županc, T. The complete genome sequence of a Crimean-Congo Hemorrhagic Fever virus isolated from an endemic region in Kosovo. Virol. J. 2008, 5, 7. [Google Scholar] [CrossRef] [PubMed]
- Pshenichnaya, N.Y.; Leblebicioglu, H.; Bozkurt, I.; Sannikova, I.V.; Abuova, G.N.; Zhuravlev, A.S.; Barut, S.; Shermetova, M.B.; Fletcher, T.E. Crimean-Congo hemorrhagic fever in pregnancy: A systematic review and case series from Russia, Kazakhstan and Turkey. Int. J. Infect. Dis. 2017, 58, 58–64. [Google Scholar] [CrossRef]
- Ergonul, O.; Celikbas, A.; Yildirim, U.; Zenciroglu, A.; Erdogan, D.; Ziraman, I.; Saracoglu, F.; Demirel, N.; Cakmak, O.; Dokuzoguz, B. Pregnancy and Crimean-Congo haemorrhagic fever. Clin. Microbiol. Infect. 2010, 16, 647–650. [Google Scholar] [CrossRef] [PubMed]
- Tsergouli, K.; Karampatakis, T.; Haidich, A.-B.; Metallidis, S.; Papa, A. Nosocomial infections caused by Crimean-Congo haemorrhagic fever virus. J. Hosp. Infect. 2020, 105, 43–52. [Google Scholar] [CrossRef] [PubMed]
- Karlberg, H.; Tan, Y.J.; Mirazimi, A. Induction of caspase activation and cleavage of the viral nucleocapsid protein in different cell types during Crimean-Congo hemorrhagic fever virus infection. J. Biol. Chem. 2011, 286, 3227–3234. [Google Scholar] [CrossRef] [PubMed]
- Spengler, J.R.; Kelly Keating, M.; McElroy, A.K.; Zivcec, M.; Coleman-McCray, J.D.; Harmon, J.R.; Bollweg, B.C.; Goldsmith, C.S.; Bergeron, É.; Keck, J.G.; et al. Crimean-Congo Hemorrhagic Fever in Humanized Mice Reveals Glial Cells as Primary Targets of Neurological Infection. J. Infect. Dis. 2017, 216, 1386–1397. [Google Scholar] [CrossRef]
- Gozel, M.G.; Elaldi, N.; Engin, A.; Akkar, O.B.; Bolat, F.; Celik, C. Favorable outcomes for both mother and baby are possible in pregnant women with Crimean-Congo hemorrhagic fever disease: A case series and literature review. Gynecol. Obstet. Investig. 2014, 77, 266–271. [Google Scholar] [CrossRef]
Days After Disease Onset | Day 9 (Arrival at UCC) | Day 9 (Transfer to ICU) | Day 10 | Day 13 | Day 18 | Day 19 | Day 25 | ||
---|---|---|---|---|---|---|---|---|---|
Parameter | Unit | Normal Values | |||||||
</ = 1:20 | |||||||||
Anti-CCHF IgG IFT | 1:160 | 1:10,240 (Day 36) | </ = 1:20 | ||||||
Anti-CCHF IgM IFT | 1:80 | 1:10,240 (Day 36) | 3.5–6.0 | ||||||
Erythrocyte Count | 3.52 | 3.05 | 3.1 | 2.3 | 4.1 | 3.5 | 3.1 | ×1012/L | 95–150 |
Hemoglobin | 95 | 82 | 84 | 68 | 121 | 94 | 95 | g/L | 3.5–10.0 |
Leukocyte Count | 26.6 | 24.2 | 22.4 | 13.8 | 14.6 | 14.1 | 9.5 | ×109/L | 150–450 |
Platelet Count | 101 | 149 | 156 | 73 | 52 | 81 | 207 | ×109/L | </ = 1:20 |
ASAT (GPT) | 2050 | 1097 | 65 | 108 | 62 | 33 | IU/L | <50 | |
ALAT (GOT) | 470 | 253 | 229 | 86 | 55 | 24 | IU/L | <50 | |
LDH | 2733 | 1511 | IU/L | <240 | |||||
Total Bilirubin | 60.5 | 61.1 | µmol/L | <20 | |||||
Prothrombin Time | 37.5 | 39.1 | Normal | s | <11 | ||||
PTT | 85 | Normal | s | 20–40 | |||||
Activated PTT | 52 | Normal | s | 20–40 | |||||
Albumin | 23.3 | 21.4 | 23 | g/L | 35–45 | ||||
Creatinine | 126 | 129 | 114 | 59 | 58 | µmol/L | <90 | ||
Urea | 9.8 | 10.4 | 10.1 | 6.1 | 4.8 | mmol/L | <7 | ||
Glucose | 5.5 | 9.9 | 3.1 | 6.6 | mmol/L | 3.5–7.5 | |||
CRP | 14.3 | 16.4 | mg/L | <5 | |||||
Procalcitonin | 0.68 | ng/mL | <0.5 | ||||||
Na | 143 | mmol/L | 135–145 | ||||||
K | 4.2 | mmol/L | 3.5–5.2 |
Days Since Cesarian Section | |||||
---|---|---|---|---|---|
Parameter | Day 0 | Day 3 | Day 6 | Unit | Normal Range |
Erythrocyte Count | 4.12 | 4.7 | 3.9 | ×1012/L | 3.5–6.0 |
Hemoglobin | 142 | 143 | 136 | g/L | 95–150 |
Hematocrit | 39.5 | % | 30–40 | ||
Leukocyte Count | 30; Left Shift | 15.3 | 17.1 | ×109/L | 3.5–10.0 |
Platelet Count | 108 | 46 | 49 | ×109/L | 150–450 |
AST (GPT) | 156 | IU/L | <50 | ||
ALT (GOT) | 56 | IU/L | <50 | ||
Creatine Kinase | 313 | IU/L | <190 | ||
Total Bilirubin | 79.3 | µmol/L | <20 | ||
Direct Bilirubin | 53.0 | µmol/L | <6 | ||
Prothrombin Time | 44.8 | s | <11 | ||
Albumin | 26.1 | g/L | 35–45 | ||
Creatinine | 85.5 | µmol/L | <90 | ||
Urea | 9.1 | mmol/L | <7 | ||
Glucose | 3.9 | mmol/L | 3.5–7.5 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ajazaj-Berisha, L.; Halili, B.; Ndrejaj, V.; Sherifi, K.; Jakupi, X.; Priesnitz, S.; Hemmer, C.J.; Ahmeti, S.; Emmerich, P. Crimean–Congo Hemorrhagic Fever Mimicking HELLP Syndrome in a Pregnant Woman and Her Infant in Kosovo: A Case Report. Viruses 2025, 17, 178. https://doi.org/10.3390/v17020178
Ajazaj-Berisha L, Halili B, Ndrejaj V, Sherifi K, Jakupi X, Priesnitz S, Hemmer CJ, Ahmeti S, Emmerich P. Crimean–Congo Hemorrhagic Fever Mimicking HELLP Syndrome in a Pregnant Woman and Her Infant in Kosovo: A Case Report. Viruses. 2025; 17(2):178. https://doi.org/10.3390/v17020178
Chicago/Turabian StyleAjazaj-Berisha, Lindita, Bahrije Halili, Vera Ndrejaj, Kurtesh Sherifi, Xhevat Jakupi, Simone Priesnitz, Christoph J. Hemmer, Salih Ahmeti, and Petra Emmerich. 2025. "Crimean–Congo Hemorrhagic Fever Mimicking HELLP Syndrome in a Pregnant Woman and Her Infant in Kosovo: A Case Report" Viruses 17, no. 2: 178. https://doi.org/10.3390/v17020178
APA StyleAjazaj-Berisha, L., Halili, B., Ndrejaj, V., Sherifi, K., Jakupi, X., Priesnitz, S., Hemmer, C. J., Ahmeti, S., & Emmerich, P. (2025). Crimean–Congo Hemorrhagic Fever Mimicking HELLP Syndrome in a Pregnant Woman and Her Infant in Kosovo: A Case Report. Viruses, 17(2), 178. https://doi.org/10.3390/v17020178